Association Insights From

Karin Hessler

Vice President and Deputy General Counsel
Association for Accessible Medicines (AAM)

David E. Korn

Vice President, Intellectual Property and Law
Pharmaceutical Research and Manufacturers of America (PhRMA)

Hans Sauer, Ph.D., J.D.

Deputy General Counsel, Vice President for Intellectual Property
Biotechnology Innovation Organization (BIO)

Hear from Government

Rainer Becker

Head of Unit, DG Competition
European Commission

Hon. Jacqueline Wright Bonilla

Deputy Chief, Administrative Patent Judge
USPTO Patent Trial and Appeal Board

Industry Acumen From

Sara Burghart

Lead IP Litigation Counsel
Global Litigation & Launch – Global IP
Sandoz International GmbH (DEU)

Monika Dorda

SVP & General Counsel Global Pharmaceuticals

James Horgan

Assistant Managing Counsel
Merck Sharp & Dohme Ltd

Guido Pontremoli, Ph.D.

Global IP Head
Corp. Intellectual Property-Patents
Chiesi Farmaceutici S.p.A.

Laura Reynolds

Associate General Counsel
European IP and Regulatory Litigation
Teva Pharmaceuticals

BREXIT and Supplementary Protection Certificates

February 25, 2021 12:15 pm

Dr. Corinna Sundermann

Senior Vice President Intellectual Property Management
Fresenius Kabi Deutschland GmbH

Dr. Dean Thomas

Vice President - Global Head of IP and Associate General Counsel
Ichnos Sciences

Shohta Ueno, PhD

Director, Dispute Resolution
Regeneron Pharmaceuticals

Willem F.C. de Weerd

Director, Corporate Patent Counsel Patents Healthcare

Esteemed Faculty

Professor Dr. Maximilian Haedicke

Professor of Intellectual Property Law
Freiburg University (DEU)
(Former Judge at higher Regional Court of Duesseldorf)

Marie Manley

Sidley Austin LLP

BREXIT and Supplementary Protection Certificates

February 25, 2021 12:15 pm

Benjamin May

ARAMIS Société d'Avocats

Erin M. Sommer, Ph.D.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP